Perricone v. Medicis Pharmaceutical Corp.

98 F. App'x 868
CourtCourt of Appeals for the Federal Circuit
DecidedMay 4, 2004
DocketNo. 04-1184
StatusPublished

This text of 98 F. App'x 868 (Perricone v. Medicis Pharmaceutical Corp.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Perricone v. Medicis Pharmaceutical Corp., 98 F. App'x 868 (Fed. Cir. 2004).

Opinion

SCHALL, Circuit Judge.

ORDER

Medicis Pharmaceutical Corporation moves to dismiss Nicholas V. Perricone, M.D.’s appeal or, in the alternative, to deactivate. Perricone opposes the motion to dismiss and consents to the motion to deactivate.

Perricone appealed from the June 16, 2003 order of the United States District Court for the District of Connecticut in Perricone v. Medicis Pharmaceutical Corp., No. 3:99 CV 1820, granting Medicis’ motions for partial summary judgment of invalidity and of noninfringement of certain claims of Perrieone’s patents.

Medicis states that the district court has not yet entered final judgment and thus moves to dismiss Perricone’s appeal for lack of jurisdiction. A review of the district court’s docket sheet reflects that a final judgment has not been entered. Therefore, we conclude that the appeal is premature and dismiss for lack of jurisdiction. See Fed.R.Civ.P. 58(a)(1) (every judgment must be set forth on a separate document).

Accordingly,

IT IS ORDERED THAT:

(1) Medicis’ motion to dismiss is granted.

Free access — add to your briefcase to read the full text and ask questions with AI

Cite This Page — Counsel Stack

Bluebook (online)
98 F. App'x 868, Counsel Stack Legal Research, https://law.counselstack.com/opinion/perricone-v-medicis-pharmaceutical-corp-cafc-2004.